Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Know Labs initiates at-the-market stock offering program

EditorNatashya Angelica
Published 03/20/2024, 04:56 PM
© Reuters.
KNW
-

In a recent development, Know Labs, Inc (NYSE:KNW), a technology company, announced its entry into an At the Market Offering Agreement (ATM Agreement) with The Benchmark Company, LLC (Benchmark) as sales agent. According to the agreement, Know Labs may intermittently offer and sell its common stock through Benchmark.

The sale of shares will be conducted under Know Labs' existing shelf registration statement, which was filed on December 22, 2023, and subsequently declared effective by the U.S. Securities and Exchange Commission (SEC) on January 5, 2024. This is further detailed in a prospectus supplement dated March 20, 2024.

Know Labs is authorized to sell up to $5 million of its shares under the ATM program. The agreement stipulates that the company will not exceed the number of shares registered, the number of authorized but unissued shares, or the limits set by Form S-3, as per SEC regulations.

Benchmark, acting as the sales agent, is entitled to a commission of up to 3.5% of the gross proceeds from the sale of shares. Additionally, Know Labs will reimburse Benchmark for certain expenses associated with the offering. Both parties have the right to suspend or terminate the offering based on specific conditions.

The offering will end upon the sale of all shares under the ATM Agreement or if the agreement is terminated. Benchmark is committed to executing sales on a commercially reasonable efforts basis, adhering to legal requirements, and the rules of the NYSE American.

This move allows Know Labs to potentially strengthen its financial position by leveraging market conditions to sell shares at prevailing market prices. The company has made it clear that there is no obligation for either Know Labs or Benchmark to sell or buy any shares, suggesting a flexible approach to the offering.

The information presented here is based on an 8K filing with the SEC, offering a factual overview of Know Labs' strategic financial maneuver.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.